1. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein
   Roger Yazbeck et al, 2018, Protoplasma CrossRef
2. The clinicopathological impact of tumor‐associated macrophages in patients with cutaneous malignant melanoma
   Yoshinari Asai et al, 2024, Journal of Surgical Oncology CrossRef
3. In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions
   Circe D. van der Heide et al, 2024, EJNMMI Radiopharmacy and Chemistry CrossRef
4. Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
   Barbara Kreppel et al, 2021, Nuklearmedizin - NuclearMedicine CrossRef
5. Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
   Joke Tommelein et al, 2015, Frontiers in Oncology CrossRef
6. Targeting CAFs
   Katie O’Fee et al, 2024, Reference Module in Biomedical Sciences CrossRef
7. Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer
   Laurine Verset et al, 2015, Radiotherapy and Oncology CrossRef
8. Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma
   Naoki Yanagawa et al, 2023, Thoracic Cancer CrossRef
9. Response Prediction Using18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
   Xinying Hu et al, 2023, Journal of Nuclear Medicine CrossRef
10. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Inigo Martinez-Zubiaurre et al, 2023, Cell Communication and Signaling CrossRef
11. Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
    W. Nathaniel Brennen et al, 2012, Molecular Cancer Therapeutics CrossRef
12. Bidirectional cross talk between patient‐derived melanoma and cancer‐associated fibroblasts promotes invasion and proliferation
    Benjamin Izar et al, 2016, Pigment Cell & Melanoma Research CrossRef
13. The Biomechanical Properties of 3d Extracellular Matrices and Embedded Cells Regulate the Invasiveness of Cancer Cells
    Claudia T. Mierke, 2011, Cell Biochemistry and Biophysics CrossRef
14. Extracellular vesicles derived from cancer-associated fibroblast carries miR-224-5p targeting SLC4A4 to promote the proliferation, invasion and migration of colorectal cancer cells
    Yu Zheng et al, 2021, Carcinogenesis CrossRef
15. Tumor microenvironment and radioresistance
    Tatsuya Suwa et al, 2021, Experimental & Molecular Medicine CrossRef
16. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells
    Xiaoqin Ji et al, 2017, Future Oncology CrossRef
17. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation
    HAN JO KIM et al, 2014, Oncology Reports CrossRef
18. 18F-FAPI-04 PET/CT parameters predict PD-L1 expression in esophageal squamous cell carcinoma
    Yaqing Zhao et al, 2023, Frontiers in Immunology CrossRef
19. Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment
    Harold Ting et al, 2016, Carcinogenesis CrossRef
20. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer
    Joana Tato-Costa et al, 2016, Clinical Colorectal Cancer CrossRef
21. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies
    Maxim Le Compte et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
22. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
    Rana Mhaidly et al, 2020, Seminars in Immunology CrossRef
23. High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes
    Mairene Coto-Llerena et al, 2020, Frontiers in Oncology CrossRef
24. Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer
    Zhenyue Chen et al, 2022, Frontiers in Oncology CrossRef
25. Regulation of the anti-tumour immune response by cancer-associated fibroblasts
    James Harper et al, 2014, Seminars in Cancer Biology CrossRef
26. Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging
    Katharina Kessel et al, 2022, Annals of Nuclear Medicine CrossRef
27. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis
    Yida Liao et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef
28. In vitro models of cancer stem cells and clinical applications
    Sara S. Franco et al, 2016, BMC Cancer CrossRef
29. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways
    Jun Jia et al, 2017, International Journal of Molecular Medicine CrossRef
30. Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways
    Sarah K. Baird et al, 2015, Clinical & Experimental Metastasis CrossRef
31. Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal Cancers
    Chao-Yang Chen et al, 2024, Cells CrossRef
32. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer
    Zhaoye Wu et al, 2022, Nuclear Medicine Communications CrossRef
33. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
    Maria L. Wikberg et al, 2013, Tumor Biology CrossRef
34. Brain metastasis: An insight into novel molecular targets for theranostic approaches
    Liliana Santos et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
35. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma
    Ling Chen et al, 2018, Journal of Clinical Pathology CrossRef
36. Targeting fibroblast activation protein with chimeric antigen receptor macrophages
    Yizhi Mao et al, 2024, Biochemical Pharmacology CrossRef
37. Identification of Commonly Dysregulated Genes in Non-small-cell Lung Cancer by Integrated Analysis of Microarray Data and qRT-PCR Validation
    Zi-Qiang Tian et al, 2015, Lung CrossRef
38. Stromal contribution to the colorectal cancer transcriptome
    Claudio Isella et al, 2015, Nature Genetics CrossRef
39. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells
    Zhi-Yu Song et al, 2015, Biomedicine & Pharmacotherapy CrossRef
40. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
    Yufang Shi et al, 2017, Nature Reviews Drug Discovery CrossRef
41. Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
    Charalampos Fotsitzoudis et al, 2022, Cancers CrossRef
42. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
    Zhanhuai Wang et al, 2019, Cell Communication and Signaling CrossRef
43. The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer
    Huajun Cai et al, 2024, Heliyon CrossRef
44. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy
    Susumu Saigusa et al, 2016, International Journal of Clinical Oncology CrossRef
45. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review
    Chao Wang et al, 2023, Oncology Research and Treatment CrossRef
46. Relationships of Alpha-SMA-Positive Fibroblasts and SDF-1-Positive Tumor Cells with Neoangiogenesis in Nasopharyngeal Carcinoma
    Shumin Wang et al, 2014, BioMed Research International CrossRef
47. Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
    Melanie Mediavilla-Varela et al, 2013, Cancer Biology & Therapy CrossRef
48. Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours
    Michal Zubaľ et al, 2023, Pathology CrossRef
49. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts
    Diana Avery et al, 2018, Matrix Biology CrossRef
50. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
    Ming Li et al, 2020, Acta Neuropathologica Communications CrossRef
51. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment
    Chunxia Ren et al, 2013, European Journal of Cancer CrossRef
52. Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells
    Amy L. Strong et al, 2015, Stem Cells CrossRef
53. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer
    Rui-Fen Wang et al, 2013, Experimental and Molecular Pathology CrossRef
54. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging
    Katharina Dendl et al, 2021, PET Clinics CrossRef
55. Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival
    Mai Hashimoto et al, 2022, Virchows Archiv CrossRef
56. The Role and Application of Fibroblast Activating Protein
    Xiao-lou Zhang et al, 2024, Current Molecular Medicine CrossRef
57. Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
    Agathe Peltier et al, 2022, Seminars in Cancer Biology CrossRef
58. Fibroblast activation protein α in tumor microenvironment: Recent progression and implications (Review)
    FUMING ZI et al, 2015, Molecular Medicine Reports CrossRef
59. A TRACER culture invasion assay to probe the impact of cancer associated fibroblasts on head and neck squamous cell carcinoma cell invasiveness
    Teresa Dean et al, 2020, Biomaterials Science CrossRef
60. Tumor stroma as targets for cancer therapy
    Jing Zhang et al, 2013, Pharmacology & Therapeutics CrossRef
61. Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts
    Nannan Yang et al, 2024, Cancer Reports CrossRef
62. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
    Zahra Kalaei et al, 2023, Cell Communication and Signaling CrossRef
63. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
    Monika Licaj et al, 2024, Nature Communications CrossRef
64. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways
    Zhi-Yu Song et al, 2018, Cancer Investigation CrossRef
65. Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers
    In-Hye Ham et al, 2021, Cancers CrossRef
66. Fibroblasts, an inconspicuous but essential player in colon cancer development and progression
    Naofumi Mukaida et al, 2016, World Journal of Gastroenterology CrossRef
67. WITHDRAWN: Targeting CAFs
    Katie O’Fee et al, 2024, Reference Module in Life Sciences CrossRef
68. Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer
    Linsong Mu et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
69. The use of a multi-metric readout screen to identify EHMT2/G9a-inhibition as a modulator of cancer-associated fibroblast activation state
    Nila C. Wu et al, 2025, Biomaterials CrossRef
70. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers
    Yu‐Wei Hsiao et al, 2022, Clinical and Translational Medicine CrossRef
71. Radiotherapy resistance: identifying universal biomarkers for various human cancers
    Irina Larionova et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
72. Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1
    Mhairi A. Morris, 2019, Pathogens CrossRef
73. Differential secretome analysis of cancer‐associated fibroblasts and bone marrow‐derived precursors to identify microenvironmental regulators of colon cancer progression
    Astrid De Boeck et al, 2013, PROTEOMICS CrossRef
74. High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma
    Naoki Yanagawa et al, 2022, Thoracic Cancer CrossRef